Author:
Feng Xingliang,Chen Yiming,Xia Wei,Zhang Bo
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–9.
2. Lu Y, Fan S, Song Y, Liu K, Zhou K, Kang J, Wang S, Yang Y, Liu X. The association between anogenital distance and benign prostatic hyperplasia related lower urinary tract symptoms in Chinese aging men. World J Urol. 2021;39(7):2645–53.
3. Zhu C, Wang DQ, Zi H, Huang Q, Gu JM, Li LY, Guo XP, Li F, Fang C, Li XD, et al. Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019. Mil Med Res. 2021;8(1):64.
4. Xia BW, Zhao SC, Chen ZP, Chen C, Liu TS, Yang F, Yan Y. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume. Prostate. 2020;80(6):481–90.
5. Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E. Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr. 2002;75(4):689–97.